Condition

Diabetes in Pregnancy

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12

Recruiting3

Common interventions17

Lead sponsors shown12

Clinical trials

12 shown

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)NCT07171684 · 2025-11-26

RECRUITING

Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled TrialNCT06355154 · 2024-05-28

RECRUITING

Hydroxychloroquine in Type 2 Diabetes During PregnancyNCT06319560 · 2024-03-24

RECRUITING

Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and SatisfactionNCT07165327 · 2025-10-01

NOT_YET_RECRUITING

Manchester Intermittent Diet in Gestational Diabetes Acceptability StudyNCT05344066 · 2022-11-24

UNKNOWN

Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational DiabetesNCT05305326 · 2021-12-01

UNKNOWN

Single Non-fasting OGTT Versus Fasting OGTT for Screening of Hyperglycaemia in Pregnancy (HIP)NCT04129190 · 2019-10-15

UNKNOWN

Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)NCT02968628 · 2016-09-01

COMPLETED

Incentives and Glucose Adherence in DiabetesNCT03338829 · 2016-05-05

COMPLETED

Meal Composition and the Influence on Pre-prandial Blood Glucose ValuesNCT03028506 · 2015-01-01

COMPLETED

Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in PregnancyNCT01973374 · 2013-01-01

COMPLETED

Haptoglobin and Diabetes Complications in PregnancyNCT01758016 · 2012-11-01

UNKNOWN

Common interventions

Best NHS CareOTHER1 Carbohydrate intakeOTHER1 GlucoseBIOLOGICAL1 Hydroxychloroquine Oral TabletDRUG1 Injection Port for Insulin AdministrationDEVICE1 Insulin glargine + insulin lisproDRUG1 Insulin glargine aloneDRUG1 Intermittent Low Energy DietOTHER1 Loss aversionBEHAVIORAL1 Maternal QuestionnaireOTHER1 Medical Record Data ExtractionOTHER1 Nutritional interventionOTHER1 Point-of Care Blood Sugar TestingOTHER1 Positive incentiveBEHAVIORAL1 Single-Use Insulin NeedlesDEVICE1 Text Message InterventionBEHAVIORAL1 Video Electroencephalogram (EEG)OTHER1

Leading sponsors

Hadassah Medical Organization 1 Isra University 1 Manchester University NHS Foundation Trust 1 National University of Malaysia 1 Rambam Health Care Campus 1 Rutgers, The State University of New Jersey 1 Sohag University 1 St. Louis University 1 University of Iowa 1 University of Pennsylvania 1 University of Rochester 1 University of Texas at Austin 1

Trial status mix

COMPLETED4

UNKNOWN4

RECRUITING3

NOT_YET_RECRUITING1

Phase mix

NA7

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.